534
Views
6
CrossRef citations to date
0
Altmetric
Review

Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders

ORCID Icon, , , , , , , , & ORCID Icon show all
Pages 301-318 | Received 12 May 2017, Accepted 18 Dec 2017, Published online: 07 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Baozhen Zhang, Lizhen Zhu, Hong Pan & Lintao Cai. (2023) Biocompatible smart micro/nanorobots for active gastrointestinal tract drug delivery. Expert Opinion on Drug Delivery 20:10, pages 1427-1441.
Read now
Liucan Wang, Min Yu & Hua Yang. (2021) Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease. Journal of Inflammation Research 14, pages 1701-1716.
Read now
Katayon Hemmati, Navid Ahmadi Nasab, Saeed Hesaraki & Nader Nezafati. (2021) In vitro evaluation of curcumin-loaded chitosan-coated hydroxyapatite nanocarriers as a potential system for effective treatment of cancer. Journal of Biomaterials Science, Polymer Edition 32:10, pages 1267-1287.
Read now
Rahul Mittal, Stefanie A. Pena, Angela Zhu, Nicolas Eshraghi, Arian Fesharaki, Elijah J. Horesh, Jeenu Mittal & Adrien A. Eshraghi. (2019) Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1312-1320.
Read now
Vu Thanh Cong, Katharina Gaus, Richard D. Tilley & J. Justin Gooding. (2018) Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives. Expert Opinion on Drug Delivery 15:9, pages 881-892.
Read now

Articles from other publishers (1)

Zhe Wang, Wei Liu, Shuping Zhang, Jie Zhang & Sijin Liu. (2018) CdSe Quantum Dots Incurred Hemoglobin RNA Transcription Inhibition in Embryonic Erythroid Precursors and Compromised Embryonic Development in Mice under Low-Dose Exposure. ACS Sustainable Chemistry & Engineering 6:3, pages 4164-4173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.